{"id":"placebo-for-oral-corticosteroids","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used as control comparators in clinical trials to measure the efficacy of an active drug against baseline or non-specific effects. In this Phase 3 trial context, the placebo serves as a comparator arm for evaluating an investigational treatment for oral corticosteroid-dependent conditions. Any observed clinical benefit in the placebo group would reflect natural disease progression, regression to the mean, or psychological/expectation effects rather than pharmacological action.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:27:17.444Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Phase 3 trial for oral corticosteroid-dependent condition (specific indication unknown)"}]},"trialDetails":[{"nctId":"NCT03663335","phase":"PHASE2","title":"Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-11-28","conditions":"Kidney Transplantation","enrollment":418},{"nctId":"NCT05268289","phase":"PHASE2","title":"Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-08-10","conditions":"Lupus Nephritis","enrollment":240},{"nctId":"NCT06585774","phase":"PHASE3","title":"A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease","status":"RECRUITING","sponsor":"Incyte Corporation","startDate":"2025-01-21","conditions":"Chronic Graft-versus-host-disease","enrollment":240},{"nctId":"NCT05811351","phase":"PHASE2","title":"A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-03-06","conditions":"Geographic Atrophy","enrollment":305},{"nctId":"NCT05986318","phase":"PHASE2","title":"Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease","status":"RECRUITING","sponsor":"David Palma","startDate":"2025-01-07","conditions":"Lung Cancer, Interstitial Lung Disease","enrollment":98},{"nctId":"NCT07450638","phase":"NA","title":"Effect of Preoperative Long-Acting Corticosteroids on Pain, Swelling, and Trismus After Impacted Lower Third Molar Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Al Salam University","startDate":"2026-01-04","conditions":"Impacted Mandibular Third Molar, Postoperative Pain, Trismus","enrollment":60},{"nctId":"NCT06076304","phase":"PHASE4","title":"Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis","status":"RECRUITING","sponsor":"Daniel Merenstein","startDate":"2023-11-21","conditions":"Sinus Infection, Acute Sinusitis","enrollment":3720},{"nctId":"NCT07440238","phase":"PHASE2","title":"Evaluation of the Efficacy of Corticosteroids in Septic Arthritis in Adults","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03-30","conditions":"Septic Arthritis","enrollment":200},{"nctId":"NCT03725202","phase":"PHASE3","title":"A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis","status":"COMPLETED","sponsor":"AbbVie","startDate":"2019-01-24","conditions":"Giant Cell Arteritis (GCA)","enrollment":429},{"nctId":"NCT06701331","phase":"PHASE3","title":"Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2024-12-22","conditions":"Atopic Dermatitis","enrollment":99},{"nctId":"NCT04161898","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2020-02-04","conditions":"Takayasu Arteritis (TAK)","enrollment":56},{"nctId":"NCT05345171","phase":"PHASE3","title":"Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2022-10-18","conditions":"OTC Deficiency","enrollment":32},{"nctId":"NCT07401992","phase":"PHASE4","title":"Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis","status":"RECRUITING","sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","startDate":"2026-01-15","conditions":"Psoriasis (PsO), Obesity & Overweight, Diabetes Mellitus - Type 2","enrollment":62},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT04918147","phase":"PHASE2","title":"Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-10-13","conditions":"IgG4 Related Disease, IgG4-RD","enrollment":8},{"nctId":"NCT06283550","phase":"PHASE2","title":"Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy","status":"COMPLETED","sponsor":"Innovaderm Research Inc.","startDate":"2024-05-31","conditions":"Chronic Hand Eczema","enrollment":82},{"nctId":"NCT07223580","phase":"PHASE4","title":"A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-01-23","conditions":"Ureteroscopy, Post Operative Pain","enrollment":90},{"nctId":"NCT07258771","phase":"PHASE4","title":"Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis","status":"RECRUITING","sponsor":"Berinstein, Jeffrey","startDate":"2026-01-16","conditions":"Ulcerative Colitis Acute","enrollment":110},{"nctId":"NCT07113158","phase":"PHASE3","title":"Effect of Aspirin and Folic Acid for Sudden Sensorineural Hearing Loss","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-04-01","conditions":"Sudden Sensorineural Hearing Loss","enrollment":142},{"nctId":"NCT06521762","phase":"PHASE2","title":"Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis","status":"WITHDRAWN","sponsor":"Yale University","startDate":"2026-01","conditions":"Immune Checkpoint Inhibitor-Related Diarrhea and Colitis","enrollment":""},{"nctId":"NCT03621553","phase":"PHASE4","title":"Vitamin D Homeostasis in Sarcoidosis","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2010-07-01","conditions":"Sarcoidosis, Vitamin D Insufficiency","enrollment":90},{"nctId":"NCT06238700","phase":"NA","title":"Study on Allopregnanolone and Depression in Women Across the Menopause Transition","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2024-05-14","conditions":"Depression","enrollment":80},{"nctId":"NCT03568318","phase":"PHASE3","title":"A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2018-08-09","conditions":"Atopic Dermatitis","enrollment":1533},{"nctId":"NCT05193396","phase":"PHASE4","title":"Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment","status":"RECRUITING","sponsor":"Marianne Andersen","startDate":"2022-02-01","conditions":"Adrenal Insufficiency, Polymyalgia Rheumatica (PMR), Giant Cell Arteritis (GCA)","enrollment":100},{"nctId":"NCT03896659","phase":"PHASE4","title":"Exploring the Effects of Corticosteroids on the Human Hippocampus","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-10-01","conditions":"Hydrocortisone, Depression, Healthy Volunteers","enrollment":66},{"nctId":"NCT07279688","phase":"PHASE3","title":"Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Brest","startDate":"2025-12-12","conditions":"Polymyalgia Rheumatica (PMR)","enrollment":140},{"nctId":"NCT05643638","phase":"PHASE2","title":"A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD","status":"RECRUITING","sponsor":"Cynata Therapeutics Limited","startDate":"2024-03-04","conditions":"Graft Versus Host Disease, Acute","enrollment":60},{"nctId":"NCT03760003","phase":"PHASE2","title":"Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis","status":"COMPLETED","sponsor":"Abivax S.A.","startDate":"2019-08-13","conditions":"Ulcerative Colitis","enrollment":355},{"nctId":"NCT04885530","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2021-06-08","conditions":"Covid19","enrollment":10956},{"nctId":"NCT03648385","phase":"PHASE2","title":"Effects of DHEA in Pulmonary Hypertension","status":"COMPLETED","sponsor":"Rhode Island Hospital","startDate":"2019-01-09","conditions":"Pulmonary Arterial Hypertension","enrollment":26},{"nctId":"NCT03584516","phase":"PHASE2, PHASE3","title":"GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease","status":"TERMINATED","sponsor":"Incyte Corporation","startDate":"2019-01-17","conditions":"Chronic Graft-versus-host Disease","enrollment":155},{"nctId":"NCT03545464","phase":"PHASE3","title":"COrticosteroids in acUte uRticAria in emerGency dEpartment","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-09-21","conditions":"Urticaria, Angiœdema","enrollment":137},{"nctId":"NCT00647166","phase":"PHASE3","title":"Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-05","conditions":"MPA, PAN or EGPA With FFS=0, At Diagnosis or Within the First 15 Days Following Initiation of Corticosteroids","enrollment":114},{"nctId":"NCT04037605","phase":"EARLY_PHASE1","title":"Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2020-02-09","conditions":"Sleep Restriction","enrollment":5},{"nctId":"NCT03142893","phase":"PHASE1","title":"Hormonal Mechanisms of Sleep Restriction - Axis Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peter y. Liu","startDate":"2017-05-08","conditions":"Sleep Restriction","enrollment":80},{"nctId":"NCT02330952","phase":"PHASE4","title":"Efficacy of Corticosteroids to Treat Outpatients With Acute Exacerbations of COPD","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-02-10","conditions":"Pulmonary Disease, Chronic Obstructive (MeSH)","enrollment":189},{"nctId":"NCT03139604","phase":"PHASE3","title":"GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2017-07-19","conditions":"Graft-versus-host Disease (GVHD)","enrollment":439},{"nctId":"NCT04643158","phase":"PHASE2","title":"Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled Corticosteroids","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2021-03-12","conditions":"Asthma","enrollment":72},{"nctId":"NCT07021495","phase":"","title":"SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-07-29","conditions":"Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO)","enrollment":840},{"nctId":"NCT04972760","phase":"PHASE3","title":"Baricitinib in Patients With Relapsing or naïve Dermatomyositis","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-08-31","conditions":"Dermatomyositis","enrollment":62},{"nctId":"NCT07112456","phase":"PHASE2","title":"Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations","status":"NOT_YET_RECRUITING","sponsor":"Oman Medical Speciality Board","startDate":"2026-09-01","conditions":"Asthma Acute, Asthma Attack, Asthma Exacerbations","enrollment":100},{"nctId":"NCT07067801","phase":"PHASE3","title":"Evaluation of Oral Corticosteroid Therapy in Idiopathic Sudden Unilateral Hearing Loss.","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2025-11","conditions":"Sudden Sensorineural Hearing Loss","enrollment":430},{"nctId":"NCT05610956","phase":"EARLY_PHASE1","title":"Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-01-01","conditions":"Ulcerative Colitis","enrollment":60},{"nctId":"NCT07037043","phase":"PHASE3","title":"Hydrocortisone Plus Fludrocortisone in High-risk Patients Undergoing for Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2025-08","conditions":"Inflammation in Cardiac Surgery","enrollment":196},{"nctId":"NCT03100786","phase":"PHASE3","title":"Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis","status":"COMPLETED","sponsor":"Oxford University Clinical Research Unit, Vietnam","startDate":"2018-02-12","conditions":"Tuberculosis, Tuberculous Meningitis, Drug-Induced Liver Injury","enrollment":702},{"nctId":"NCT03365687","phase":"PHASE3","title":"Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers","status":"COMPLETED","sponsor":"Professor Francine Ducharme","startDate":"2018-10-01","conditions":"Asthma, Asthma Exacerbations, Preschool Child","enrollment":323},{"nctId":"NCT04456673","phase":"PHASE3","title":"Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation","status":"COMPLETED","sponsor":"Sanofi","startDate":"2020-07-06","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":935},{"nctId":"NCT05415137","phase":"PHASE3","title":"Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"aTyr Pharma, Inc.","startDate":"2022-09-15","conditions":"Pulmonary Sarcoidosis","enrollment":268},{"nctId":"NCT05638087","phase":"PHASE3","title":"Dexamethasone Treatment for OSA in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Hospital for Sick Children","startDate":"2022-10-26","conditions":"Obstructive Sleep Apnea","enrollment":10},{"nctId":"NCT06969495","phase":"NA","title":"Pilot Clinical Study Testing Tiger Milk Mushroom Gel (Lignosus Rhinocerus TM02®) for Treating Mouth Ulcers","status":"COMPLETED","sponsor":"Mahsa University","startDate":"2023-02-01","conditions":"Mouth Ulcer","enrollment":21},{"nctId":"NCT01353313","phase":"PHASE3","title":"Hydrocortisone for BPD","status":"COMPLETED","sponsor":"NICHD Neonatal Research Network","startDate":"2011-08-11","conditions":"Infant, Newborn, Infant, Small for Gestational Age, Infant, Very Low Birth Weight","enrollment":800},{"nctId":"NCT05063994","phase":"PHASE3","title":"Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia","status":"COMPLETED","sponsor":"Neurocrine UK Limited","startDate":"2022-05-24","conditions":"Congenital Adrenal Hyperplasia","enrollment":55},{"nctId":"NCT04072822","phase":"PHASE2","title":"Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis","status":"COMPLETED","sponsor":"Indiana University","startDate":"2020-07-10","conditions":"Alcoholic Hepatitis","enrollment":147},{"nctId":"NCT05349006","phase":"PHASE3","title":"Azathioprine in MOGAD","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2023-12-12","conditions":"Central Nervous System Inflammation, MOG-IgG Associated Disease","enrollment":126},{"nctId":"NCT04612790","phase":"PHASE3","title":"A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2021-03-31","conditions":"Bullous Pemphigoid","enrollment":67},{"nctId":"NCT04972968","phase":"PHASE2","title":"A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154","status":"TERMINATED","sponsor":"AbbVie","startDate":"2021-09-09","conditions":"Polymyalgia Rheumatica","enrollment":181},{"nctId":"NCT05542355","phase":"PHASE1","title":"EXL01 in the Maintenance of Steroid-induced Clinical Response/Remission in Participants With Mild to Moderate Crohn's Disease","status":"TERMINATED","sponsor":"Exeliom Biosciences","startDate":"2023-03-20","conditions":"Crohn Disease","enrollment":8},{"nctId":"NCT03418779","phase":"PHASE2, PHASE3","title":"Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-07-04","conditions":"IgA Nephropathy at High Risk of Developing ESRD","enrollment":60},{"nctId":"NCT04058028","phase":"PHASE2","title":"Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)","status":"COMPLETED","sponsor":"Amgen","startDate":"2020-02-19","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":244},{"nctId":"NCT06595355","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin","status":"RECRUITING","sponsor":"Isfahan University of Medical Sciences","startDate":"2021-10-10","conditions":"Diabetic Macular Edema, Macular Edema, Retinal Neovascularization","enrollment":52},{"nctId":"NCT02991768","phase":"PHASE2","title":"Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients","status":"TERMINATED","sponsor":"University of Kansas Medical Center","startDate":"2017-01-27","conditions":"Diarrhea","enrollment":9},{"nctId":"NCT05059873","phase":"PHASE4","title":"Treatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil Levels","status":"TERMINATED","sponsor":"Capital Medical University","startDate":"2023-03-05","conditions":"Acute Exacerbation of COPD, Corticosteroid, Morality","enrollment":11},{"nctId":"NCT04632940","phase":"PHASE3","title":"Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD","status":"TERMINATED","sponsor":"Kyntra Bio","startDate":"2021-03-03","conditions":"Duchenne Muscular Dystrophy","enrollment":73},{"nctId":"NCT00092989","phase":"PHASE3","title":"Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-07","conditions":"Asthma","enrollment":650},{"nctId":"NCT06522100","phase":"PHASE3","title":"Corticoid Therapy in Acute Myocarditis","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-02-01","conditions":"Acute Myocarditis","enrollment":420},{"nctId":"NCT04232449","phase":"PHASE3","title":"Oral Corticosteroids for Post-infectious Cough in Adults","status":"TERMINATED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-11-06","conditions":"Post-infectious Cough","enrollment":32},{"nctId":"NCT03093259","phase":"PHASE2","title":"ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis","status":"COMPLETED","sponsor":"Abivax S.A.","startDate":"2017-11-16","conditions":"Ulcerative Colitis","enrollment":32},{"nctId":"NCT03428100","phase":"PHASE3","title":"A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2018-05-15","conditions":"Atopic Dermatitis","enrollment":463},{"nctId":"NCT03299322","phase":"PHASE2","title":"A Study to Assess Jia Wei Yang He Formula as a Plus Therapy in the Treatment of Persistent Asthma","status":"UNKNOWN","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2017-10-01","conditions":"Bronchial Asthma","enrollment":240},{"nctId":"NCT03645096","phase":"PHASE1","title":"Development of Pregnenolone as a Treatment for Depression","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-09-01","conditions":"Major Depressive Disorder","enrollment":34},{"nctId":"NCT04809623","phase":"PHASE1","title":"Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)","status":"TERMINATED","sponsor":"Gilead Sciences","startDate":"2021-09-01","conditions":"Cutaneous Lupus Erythematosus","enrollment":3},{"nctId":"NCT03092817","phase":"PHASE3","title":"Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)","status":"COMPLETED","sponsor":"Oxford University Clinical Research Unit, Vietnam","startDate":"2017-05-25","conditions":"Tuberculosis, Tuberculous Meningitis, Drug-Induced Liver Injury","enrollment":520},{"nctId":"NCT04371666","phase":"PHASE3","title":"Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD)","status":"TERMINATED","sponsor":"Kyntra Bio","startDate":"2020-08-10","conditions":"Duchenne Muscular Dystrophy","enrollment":98},{"nctId":"NCT03930732","phase":"PHASE3","title":"Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-04-15","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":939},{"nctId":"NCT06272032","phase":"EARLY_PHASE1","title":"Prospective Multicenter Observational Study and Promotion of the Application of Focused Ultrasound in Allergic Rhinitis","status":"UNKNOWN","sponsor":"Chongqing Medical University","startDate":"2023-08-01","conditions":"Allergic Rhinitis","enrollment":240},{"nctId":"NCT05387707","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis","status":"TERMINATED","sponsor":"Cara Therapeutics, Inc.","startDate":"2022-08-16","conditions":"Pruritus, Atopic Dermatitis","enrollment":287},{"nctId":"NCT06266221","phase":"PHASE3","title":"Severe Erythema Multiforme - CORTICO","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-05-01","conditions":"Erythema Multiforme","enrollment":96},{"nctId":"NCT03752307","phase":"PHASE1, PHASE2","title":"Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2019-02-15","conditions":"Multiple Sclerosis","enrollment":2},{"nctId":"NCT04738318","phase":"PHASE4","title":"Steroid Administration for Articular Fractures of the Elbow (SAFE Trial)","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2022-06-16","conditions":"Elbow Fracture","enrollment":3},{"nctId":"NCT03827018","phase":"PHASE2","title":"KPL-301 for Subjects With Giant Cell Arteritis","status":"COMPLETED","sponsor":"Kiniksa Pharmaceuticals, Ltd.","startDate":"2018-09-20","conditions":"Giant Cell Arteritis","enrollment":70},{"nctId":"NCT04654507","phase":"PHASE3","title":"Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children","status":"UNKNOWN","sponsor":"Hamad Medical Corporation","startDate":"2021-03-03","conditions":"Urinary Tract Infections in Children, Dexamethasone, Kidney Scarring","enrollment":120},{"nctId":"NCT03824392","phase":"PHASE1, PHASE2","title":"Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis","status":"COMPLETED","sponsor":"aTyr Pharma, Inc.","startDate":"2019-01-29","conditions":"Pulmonary Sarcoidosis","enrollment":37},{"nctId":"NCT01108627","phase":"PHASE4","title":"Effect of Gly16Arg Polymorphism in ADRB2 Gene on Asthma Control in Children Receiving Long Acting Beta Agonists","status":"WITHDRAWN","sponsor":"Nemours Children's Clinic","startDate":"2010-10","conditions":"Safety of Long Acting Beta Agnoists","enrollment":""},{"nctId":"NCT03728504","phase":"PHASE2","title":"Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema","status":"COMPLETED","sponsor":"Asana BioSciences","startDate":"2019-01-03","conditions":"Chronic Hand Dermatitis","enrollment":97},{"nctId":"NCT03491007","phase":"PHASE2","title":"Neurosteroids in PTSD - Biomarkers to Therapeutics","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2019-07-08","conditions":"Posttraumatic Stress Disorder","enrollment":5},{"nctId":"NCT02028884","phase":"PHASE3","title":"Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2014-02-20","conditions":"Neuromyelitis Optica (NMO), NMO Spectrum Disorder (NMOSD)","enrollment":85},{"nctId":"NCT02959944","phase":"PHASE3","title":"Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)","status":"COMPLETED","sponsor":"Pharmacyclics LLC.","startDate":"2017-05-11","conditions":"Chronic Graft Versus Host Disease","enrollment":193},{"nctId":"NCT03661138","phase":"PHASE3","title":"A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis","status":"COMPLETED","sponsor":"AbbVie","startDate":"2018-10-27","conditions":"Atopic Dermatitis","enrollment":272},{"nctId":"NCT01086540","phase":"PHASE2","title":"Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-06-24","conditions":"Systemic Sclerosis-Associated PAH","enrollment":57},{"nctId":"NCT03674294","phase":"PHASE3","title":"Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2015-08-04","conditions":"Gastrointestinal Neoplasms, Chemotherapy-induced Nausea and Vomiting","enrollment":248},{"nctId":"NCT05449444","phase":"PHASE2","title":"Masitinib for the Treatment of Severe Mast Cell Activation Syndrome","status":"UNKNOWN","sponsor":"AB Science","startDate":"2022-07-01","conditions":"Mast Cell Activation Syndrome","enrollment":72},{"nctId":"NCT03548246","phase":"PHASE2","title":"Androgen Reduction in Congenital Adrenal Hyperplasia","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2023-01","conditions":"Congenital Adrenal Hyperplasia","enrollment":""},{"nctId":"NCT01002742","phase":"PHASE3","title":"Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2010-01","conditions":"Graft-versus-Host Disease, Immune System Disorders","enrollment":236},{"nctId":"NCT03782532","phase":"PHASE3","title":"Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-01-25","conditions":"Asthma","enrollment":486},{"nctId":"NCT05578482","phase":"PHASE4","title":"Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis","status":"UNKNOWN","sponsor":"Jacob Pontoppidan Thyssen","startDate":"2022-10-24","conditions":"Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis Flare","enrollment":45},{"nctId":"NCT05598411","phase":"PHASE4","title":"CST1-Guided Oral Glucocorticoids Management for CRSwNP","status":"UNKNOWN","sponsor":"Beijing Tongren Hospital","startDate":"2022-10-17","conditions":"Chronic Rhinosinusitis With Nasal Polyps, Glucocorticoids","enrollment":90},{"nctId":"NCT02460874","phase":"PHASE1, PHASE2","title":"Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)","status":"TERMINATED","sponsor":"University of Alabama at Birmingham","startDate":"2017-08-16","conditions":"Cerebral Edema, Brain Metastases","enrollment":1},{"nctId":"NCT02043587","phase":"PHASE2","title":"Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma","status":"TERMINATED","sponsor":"University of California, San Diego","startDate":"2014-01","conditions":"Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma","enrollment":31},{"nctId":"NCT02948959","phase":"PHASE3","title":"Evaluation of Dupilumab in Children With Uncontrolled Asthma","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-04-21","conditions":"Asthma","enrollment":408},{"nctId":"NCT01232283","phase":"PHASE3","title":"Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-11-22","conditions":"Plaque Psoriasis","enrollment":413}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":384,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo for oral corticosteroids","genericName":"Placebo for oral corticosteroids","companyName":"Ultragenyx Pharmaceutical Inc","companyId":"ultragenyx-pharmaceutical-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Control arm in Phase 3 trial for oral corticosteroid-dependent condition (specific indication unknown).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}